1. Home
  2. AMC vs IRON Comparison

AMC vs IRON Comparison

Compare AMC & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Entertainment Holdings Inc.

AMC

AMC Entertainment Holdings Inc.

N/A

Current Price

$3.05

Market Cap

2.6B

ML Signal

N/A

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$81.41

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMC
IRON
Founded
1920
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.4B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
AMC
IRON
Price
$3.05
$81.41
Analyst Decision
Hold
Strong Buy
Analyst Count
7
13
Target Price
$3.37
★ $125.75
AVG Volume (30 Days)
★ 19.7M
1.3M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $4,848,900,000.00
N/A
Revenue This Year
$17.99
N/A
Revenue Next Year
$2.32
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 4.57
N/A
52 Week Low
$0.93
$40.00
52 Week High
$3.40
$99.50

Technical Indicators

Market Signals
Indicator
AMC
IRON
Relative Strength Index (RSI) 56.75 64.04
Support Level $2.34 $73.04
Resistance Level $3.20 $83.09
Average True Range (ATR) 0.16 4.21
MACD -0.01 2.03
Stochastic Oscillator 64.29 85.13

Price Performance

Historical Comparison
AMC
IRON

About AMC AMC Entertainment Holdings Inc.

AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: